CBSA Forum attracts industry, political leaders to spotlight life science innovation in state

Wednesday August 31, 2016 0 comments Tags: Denver, CBSA, CBSA 2016 Colorado Life Science Innovation Forum, Mike Genau, Rep. Diana DeGette, Gov. John Hickenlooper, April Giles, SiVEC Biotechnologies

DENVER -- Colorado BioScience Association (CBSA) brought together political leaders, corporate executives, academics and entrepreneurs from Colorado and across the nation to examine the issues driving healthcare and life science innovation during the Colorado Life Science Innovation Forum.CBSA_Innovation_Forum_logoUSE

The forum, held Aug. 26 at the Hyatt Regency Convention Center in Denver, included keynote addresses by U.S. Rep. Diana DeGette and Mike Genau, president of Medtronic Americas.

Gov. John Hickenlooper also addressed the forum, lauding the state’s life science sector for its work to uncover cures and advance human health..

DeGette highlighted the progress of the bi-partisan 21st Century Cures legislation and predicted it would be passed by the Senate following the presidential election.

Genau re-affirmed Medtronic’s commitment to the state of Colorado. The company employs 2,500 in three Front Range locations.

Companies, providers and non-profits emphasized the importance of partnership in the research and development process, and called on the FDA to speed up trial periods for potentially life-saving therapies.

Colorado life science entrepreneurs highlighted the state of Colorado as a great place to start and commercialize a life science company.

“CBSA is honored to bring together such high-caliber speakers, leaders and thinkers to accelerate opportunities for the state’s life science sector, feature Colorado’s leadership on national industry conversations and support robust discussions on healthcare trends,” said April Giles, CBSA president and CEO.

The forum promoted early-stage companies with a Venture Showcase, with three emerging companies, selected through a rigorous application process, pitching their innovative technologies to a panel of investors, gaining exposure in the sector and access to critical funding.

The judges awarded a $7,500 cash prize to SiVEC Biotechnologies as the Venture Showcase winner. The company develops antiviral products delivered via aerosol to prevent the avian flu in poultry.